TickerFacts.

Insulet Corp (PODD): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2017-12-31, 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$301.10M
Year ended 2025-12-31
$345.90M
Trailing 12 months to 2026-06-30
+18.7%
3-year compound annual growth
+15.5%
5-year compound annual growth
2009-12-31: $13.23M2010-12-31: $16.57M2011-12-31: $21.86M2012-12-31: $24.36M2013-12-31: $21.77M2014-12-31: $27.90M2015-12-31: $43.21M2016-12-31: $55.71M2017-12-31: $75.70M2018-12-31: $94.80M2019-12-31: $132.30M2020-12-31: $146.80M2021-12-31: $160.10M2022-12-31: $180.20M2023-12-31: $205.00M2024-12-31: $219.60M2025-12-31: $301.10M$301.10M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$301.10M+37.1%2026-02-18, From 2025-01-01
2024-12-31$219.60M+7.1%2026-02-18, From 2024-01-01
2023-12-31$205.00M+13.8%2026-02-18, From 2023-01-01
2022-12-31$180.20M+12.6%2025-02-21, From 2022-01-01
2021-12-31$160.10M+9.1%2024-02-23, From 2021-01-01
2020-12-31$146.80M+11.0%2023-02-24, From 2020-01-01
2019-12-31$132.30M+39.6%2022-02-24, From 2019-01-01
2018-12-31$94.80Mn/c2021-02-24, From 2018-01-01
2017-12-31$75.70Mn/c2020-02-26, From 2017-01-01
2016-12-31$55.71M+28.9%2019-02-26, From 2016-01-01
2015-12-31$43.21M+54.9%2018-02-22, From 2015-01-01
2014-12-31$27.90M+28.2%2017-02-28, From 2014-01-01
2013-12-31$21.77M-10.6%2016-02-29, From 2013-01-01
2012-12-31$24.36M+11.4%2015-02-26, From 2012-01-01
2011-12-31$21.86M+32.0%2014-02-28, From 2011-01-01
2010-12-31$16.57M+25.2%2013-02-28, From 2010-01-01
2009-12-31$13.23Mn/a2013-02-28, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Insulet Corp (PODD)2025-12-31$301.10M+37.1%
Globus Medical Inc (GMED)2025-12-31$147.25M-10.1%
West Pharmaceutical Services Inc (WST)2025-12-31$74.30M+7.5%
MiniMed Group, Inc. (MMED)2026-04-24$448.00M+2.8%
ICU Medical Inc (ICUI)2025-12-31$87.50M-1.3%
Teleflex Inc (TFX)2025-12-31$144.78M+32.8%
Integra Lifesciences Holdings Corp (IART)2025-12-31$98.97M-14.2%
Dexcom Inc (DXCM)2025-12-31$599.10M+8.5%
Merit Medical Systems Inc (MMSI)2025-12-31$97.35M+11.3%

Compare PODD, GMED, WST, MMED side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗